ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio Corp. announced today that it will present compelling new data highlighting key milestones in the development of its novel non-inflammatory nanoemulsion adjuvant platform technology at the National Foundation for Infectious Diseases (NFID) conference, April 27-29. The new data will be delivered in two presentations during the 12th Annual Conference on Vaccine Research in Baltimore, Maryland.
